Compare Abbott India with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TORRENT PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA TORRENT PHARMA ABBOTT INDIA/
TORRENT PHARMA
 
P/E (TTM) x 56.1 39.5 141.9% View Chart
P/BV x 16.6 8.6 193.1% View Chart
Dividend Yield % 0.4 0.7 58.5%  

Financials

 ABBOTT INDIA   TORRENT PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
TORRENT PHARMA
Mar-19
ABBOTT INDIA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs8,8341,964 449.8%   
Low Rs5,4581,245 438.4%   
Sales per share (Unadj.) Rs1,731.1453.4 381.8%  
Earnings per share (Unadj.) Rs211.925.8 821.9%  
Cash flow per share (Unadj.) Rs219.962.3 353.0%  
Dividends per share (Unadj.) Rs65.0017.00 382.4%  
Dividend yield (eoy) %0.91.1 85.9%  
Book value per share (Unadj.) Rs945.2279.2 338.6%  
Shares outstanding (eoy) m21.25169.22 12.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.5 116.7%   
Avg P/E ratio x33.762.2 54.2%  
P/CF ratio (eoy) x32.525.8 126.2%  
Price / Book Value ratio x7.65.7 131.5%  
Dividend payout %30.765.9 46.5%   
Avg Mkt Cap Rs m151,848271,513 55.9%   
No. of employees `0003.513.6 25.6%   
Total wages/salary Rs m4,35614,038 31.0%   
Avg. sales/employee Rs Th10,555.55,642.6 187.1%   
Avg. wages/employee Rs Th1,249.91,032.4 121.1%   
Avg. net profit/employee Rs Th1,292.2320.9 402.7%   
INCOME DATA
Net Sales Rs m36,78676,728 47.9%  
Other income Rs m1,133571 198.6%   
Total revenues Rs m37,91977,299 49.1%   
Gross profit Rs m6,04719,831 30.5%  
Depreciation Rs m1696,177 2.7%   
Interest Rs m235,038 0.4%   
Profit before tax Rs m6,9899,187 76.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m2,4851,254 198.3%   
Profit after tax Rs m4,5034,363 103.2%  
Gross profit margin %16.425.8 63.6%  
Effective tax rate %35.613.6 260.6%   
Net profit margin %12.25.7 215.3%  
BALANCE SHEET DATA
Current assets Rs m27,61050,375 54.8%   
Current liabilities Rs m8,56951,653 16.6%   
Net working cap to sales %51.8-1.7 -3,108.1%  
Current ratio x3.21.0 330.4%  
Inventory Days Days6092 65.4%  
Debtors Days Days2768 40.1%  
Net fixed assets Rs m1,05783,648 1.3%   
Share capital Rs m213846 25.1%   
"Free" reserves Rs m19,87346,397 42.8%   
Net worth Rs m20,08647,244 42.5%   
Long term debt Rs m039,129 0.0%   
Total assets Rs m29,409141,209 20.8%  
Interest coverage x311.62.8 11,035.3%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x1.30.5 230.2%   
Return on assets %15.46.7 231.2%  
Return on equity %22.49.2 242.8%  
Return on capital %34.912.3 283.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36922,103 1.7%   
Fx outflow Rs m4,9185,522 89.1%   
Net fx Rs m-4,54916,581 -27.4%   
CASH FLOW
From Operations Rs m4,99117,981 27.8%  
From Investments Rs m-2,570-2,413 106.5%  
From Financial Activity Rs m-1,428-13,145 10.9%  
Net Cashflow Rs m9932,380 41.7%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.0 112.5%  
FIIs % 0.1 12.6 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 8.8 194.3%  
Shareholders   18,270 26,511 68.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   WYETH LTD  IPCA LABS  ALKEM LABORATORIES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 3, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ELDER PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS